Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Bjerke

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Research in Toxicology|April 9, 2026
A framework for the safety evaluation of peptides in cosmeticsDonald L Bjerke, Jin Li, Yuan Gao, et al.
Contact Dermatitis|December 18, 2003
Quantitative risk assessment for the induction of allergic contact dermatitis: uncertainty factors for mucosal exposuresMiranda A Farage, Donald L Bjerke, Catherine Mahony, et al.
Contact Dermatitis|March 5, 2004
A modified human repeat insult patch test for extended mucosal tissue exposureMiranda A Farage, Donald L Bjerke, Catherine Mahony, et al.
Regulatory Toxicology and Pharmacology : RTP|March 16, 2022
A framework to mitigate the risk of chemical leukoderma: Consumer productsDonald L Bjerke, Shengde Wu, Kazumasa Wakamatsu, et al.
Regulatory Toxicology and Pharmacology : RTP|February 10, 2015
Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocaminesJulie A Skare, Karen Blackburn, Shengde Wu, et al.
Regulatory Toxicology and Pharmacology : RTP|March 7, 2013
Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS)Nigel P Moore, David J Andrew, Donald L Bjerke, et al.
Experimental Dermatology|October 24, 2020
The vitamin A ester retinyl propionate has a unique metabolic profile and higher retinoid-related bioactivity over retinol and retinyl palmitate in human skin modelsDonald L Bjerke, Rui Li, Jason M Price, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Research in Toxicology|April 9, 2026
A framework for the safety evaluation of peptides in cosmeticsDonald L Bjerke, Jin Li, Yuan Gao, et al.
Contact Dermatitis|December 18, 2003
Quantitative risk assessment for the induction of allergic contact dermatitis: uncertainty factors for mucosal exposuresMiranda A Farage, Donald L Bjerke, Catherine Mahony, et al.
Contact Dermatitis|March 5, 2004
A modified human repeat insult patch test for extended mucosal tissue exposureMiranda A Farage, Donald L Bjerke, Catherine Mahony, et al.
Regulatory Toxicology and Pharmacology : RTP|March 16, 2022
A framework to mitigate the risk of chemical leukoderma: Consumer productsDonald L Bjerke, Shengde Wu, Kazumasa Wakamatsu, et al.
Regulatory Toxicology and Pharmacology : RTP|February 10, 2015
Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocaminesJulie A Skare, Karen Blackburn, Shengde Wu, et al.
Regulatory Toxicology and Pharmacology : RTP|March 7, 2013
Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS)Nigel P Moore, David J Andrew, Donald L Bjerke, et al.
Experimental Dermatology|October 24, 2020
The vitamin A ester retinyl propionate has a unique metabolic profile and higher retinoid-related bioactivity over retinol and retinyl palmitate in human skin modelsDonald L Bjerke, Rui Li, Jason M Price, et al.
Pageof 1